1028486-06-7

Basic information

• Product Name: 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate sodium salt
• Synonyms: 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate sodium salt
• CAS NO: 1028486-06-7
• Molecular Weight: 540.913
• Mol File: 1028486-06-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate sodium salt(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate sodium salt(1028486-06-7)
• EPA Substance Registry System: 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate sodium salt(1028486-06-7)

Safety Data

• Hazardous Substances Data: 1028486-06-7(Hazardous Substances Data)

Upstream product

• 27492-84-8 Methyl 4-amino-2-methoxybenzoate 
• 869365-97-9 (5-chloro-2-iodophenyl)(2,6-difluorophenyl)methanone 
• 28910-83-0 (2-amino-5-chlorophenyl)-(2,6-difluorophenyl)methanone 
• 869366-70-1 tert-butyl {3-[4-chloro-2-(2-fluoro-6-methoxybenzoyl)phenyl]prop-2-yn-1-yl}carbamate 
• 1028486-01-2 alisertib 
• 1233025-91-6 (5-chloro-2-iodophenyl)(2-fluoro-6-methoxyphenyl)methanone 
• 1332307-86-4 methyl 4-{[ammo(imino)methyl]amino}-2-methoxybenzoate nitrate 
• 869365-89-9 (2-amino-5-chlorophenyl)(2-fluoro-6-methoxyphenyl)methanone 
• 869367-33-9 8-chloro-4-[(dimethylamino)methylene]-1-(2-fluoro-6-methoxyphenyl)-3,4-dihydro-5H-2-benzazepin-5-one 
• 869367-01-1 8-chloro-1-(2-fluoro-6-methoxyphenyl)-3,4-dihydrobenzo[c]azepin-5-one 
• 1310-73-2 sodium hydroxide 

Relevant articles and documents

MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors

The Aurora kinases are essential for cell mitosis, and the dysregulation of Aurora A and B have been linked to the etiology of human cancers. Investigational agents MLN8054 (8) and alisertib (MLN8237, 10) have been identified as high affinity, selective,

COMPOUNDS FOR INHIBITING MITOTIC PROGRESSION

The present invention relates to compounds of formula (I) : and methods for the treatment of cancer. In particular, the invention provides potent inhibitors of Aurora A kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.